Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Lung Cancer

Free Subscription 19.10.2020 1 Ann Oncol 2 Ann Thorac Surg 1 Arch Pathol Lab Med 1 BMC Cancer 1 Cancer Cell 8 Chest 1 Clin Cancer Res 1 Clin Lung Cancer 2 Eur J Cancer 1 Eur J Cardiothorac Surg 1 Int J Cancer 1 J Nucl Med 1 J Thorac Oncol 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. TAN L, Solomon BJ
   Defining Resistance Mechanisms to Selective RET Tyrosine Kinase Inhibitors in RET Fusion-Positive Non-Small Cell Lung Cancer (editorial re: Lin et al.).
   Ann Oncol. 2020 Oct 9. pii: S0923-7534(20)42493.
   PubMed        
   
   

   
   Ann Thorac Surg

2. DARLING GE, Tammemagi MC, Schmidt H, Buchanan DN, et al
   Organized Lung Cancer Screening Pilot: Informing a Province-wide Program in Ontario, Canada.
   Ann Thorac Surg. 2020 Oct 8. pii: S0003-4975(20)31623.
   PubMed         Abstract available
   
   
3. LECLERE JB, Fournel L, Etienne H, Al Zreibi C, et al
   Maintaining surgical treatment of non-small cell lung cancer during the COVID-19 pandemic in Paris.
   Ann Thorac Surg. 2020 Oct 7. pii: S0003-4975(20)31631.
   PubMed         Abstract available
   
   

   
   Arch Pathol Lab Med

4. STAAF J, Tran L, Soderlund L, Nodin B, et al
   Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.
   Arch Pathol Lab Med. 2020;144:1075-1085.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. LENG D, Yi J, Xiang M, Zhao H, et al
   Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
   BMC Cancer. 2020;20:986.
   PubMed         Abstract available
   
   

   
   Cancer Cell

6. LIANG W, Liu J, He J
   Driving the Improvement of Lung Cancer Prognosis.
   Cancer Cell. 2020;38:449-451.
   PubMed         Abstract available
   
   

   
   Chest

7. VERDIAL FC, Berfield KS, Wood DE, Mulligan MS, et al
   Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and Mediastinoscopy.
   Chest. 2020;157:686-693.
   PubMed         Abstract available
   
   
8. WAHIDI MM, Herth FJF, Chen A, Cheng G, et al
   State of the Art: Interventional Pulmonology.
   Chest. 2020;157:724-736.
   PubMed         Abstract available
   
   
9. GRUDEN JF, Naidich DP, Machnicki SC, Cohen SL, et al
   An Algorithmic Approach to the Interpretation of Diffuse Lung Disease on Chest CT Imaging: A Theory of Almost Everything.
   Chest. 2020;157:612-635.
   PubMed         Abstract available
   
   
10. GIBIER JB, Colombat M, Grardel N, de Charette M, et al
    An 80-Year-Old Woman With a Solitary Pulmonary Nodule.
    Chest. 2020;157:e85-e89.
    PubMed         Abstract available
    
    
11. YANG H, Hall SRR, Yao F
    The Value of PD-L1 Expression in Metastatic Lymph Nodes of Advanced Non-Small Cell Lung Cancer.
    Chest. 2020;158:1785-1787.
    PubMed        
    
    
12. BRAILLON A
    Lung Cancer Screening: No Shared Decision-making When Overlooking Carl Rogers.
    Chest. 2020;158:1795-1796.
    PubMed        
    
    
13. 
    Correction to Text in: Lung Cancer Screening Uptake in the United States.
    Chest. 2020;158:1797.
    PubMed        
    
    
14. KUNITOMO Y, Young G, Datta R, Korn LL, et al
    A 62-Year-Old Woman With Lung Cancer, Ulcerating Rash, and Rapidly Progressive Hypoxemia.
    Chest. 2020;158:e191-e196.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

15. YU HA, Paz-Ares LG, Yang JC, Lee KH, et al
    Phase 1 Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-Positive EGFR-Mutant Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2020 Oct 12. pii: 1078-0432.CCR-20-1690.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

16. CUSHMAN TR, Jones B, Akhavan D, Rusthoven CG, et al
    The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States.
    Clin Lung Cancer. 2020 Sep 18. pii: S1525-7304(20)30265.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

17. TAI YH, Wu HL, Mandell MS, Lin SP, et al
    The association of non-small cell lung cancer recurrence with allogenic blood transfusion after surgical resection: A propensity score analysis of 1,803 patients.
    Eur J Cancer. 2020;140:45-54.
    PubMed         Abstract available
    
    
18. SHIRASAWA M, Yoshida T, Matsumoto Y, Shinno Y, et al
    Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer.
    Eur J Cancer. 2020;140:28-36.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

19. HANDA Y, Tsutani Y, Okada M
    Reply to Li and Che.
    Eur J Cardiothorac Surg. 2020;57:614-615.
    PubMed        
    
    

    
    Int J Cancer

20. WAH W, Stirling RG, Ahern S, Earnest A, et al
    Influence of Timeliness and Receipt of First Treatment on Geographic Variation in Non-small Cell Lung Cancer Mortality.
    Int J Cancer. 2020 Oct 12. doi: 10.1002/ijc.33343.
    PubMed         Abstract available
    
    

    
    J Nucl Med

21. CHRISTENSEN TN, Langer SW, Persson GF, Larsen KR, et al
    (18)F-FLT-PET/CT adds value to (18)F-FDG-PET/CT for diagnosing relapse after definitive radiotherapy in patients with lung cancer. Results of a prospective clinical trial.
    J Nucl Med. 2020 Oct 9. pii: jnumed.120.247742. doi: 10.2967/jnumed.120.247742.
    PubMed         Abstract available
    
    

    
    J Thorac Oncol

22. STINCHCOMBE TE, Doebele RC, Wang X, Gerber DE, et al
    Brief report: Preliminary clinical and molecular analysis results from a single arm phase 2 trial of brigatinib in patients with disease progression after next-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors in advanced ALK + no
    J Thorac Oncol. 2020 Oct 8. pii: S1556-0864(20)30764.
    PubMed         Abstract available
    
    

    
    Oncogene

23. SHEN H, Wang GC, Li X, Ge X, et al
    S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
    Oncogene. 2020 Oct 9. pii: 10.1038/s41388-020-01497.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: